Clinical Trial Update: Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated arsenic trioxide in basal cell carcinoma of the skin, including recurrent skin cancer. The results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma of the Skin
• Skin Cancer

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Stanford University | Conditions: Basal Cell Carcinoma of the Skin, Recurrent Skin Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-10-28